相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Molecular mechanisms of arrhythmogenic cardiomyopathy
Karyn M. Austin et al.
NATURE REVIEWS CARDIOLOGY (2019)
Disruption of Ca2+i Homeostasis and Connexin 43 Hemichannel Function in the Right Ventricle Precedes Overt Arrhythmogenic Cardiomyopathy in Plakophilin-2-Deficient Mice
Joon-Chul Kim et al.
CIRCULATION (2019)
Therapeutic Modulation of the Immune Response in Arrhythmogenic Cardiomyopathy
Stephen P. Chelko et al.
CIRCULATION (2019)
Mitochondrial Dysfunction as Substrate for Arrhythmogenic Cardiomyopathy: A Search for New Disease Mechanisms
Chantal J. M. van Opbergen et al.
FRONTIERS IN PHYSIOLOGY (2019)
Blockade of the Adenosine 2A Receptor Mitigates the Cardiomyopathy Induced by Loss o Plakophilin-2 Expression
Marina Cerrone et al.
FRONTIERS IN PHYSIOLOGY (2018)
Arrhythmogenic Right Ventricular Cardiomyopathy
Domenico Corrado et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Plakophilin-2 is required for transcription of genes that control calcium cycling and cardiac rhythm
Marina Cerrone et al.
NATURE COMMUNICATIONS (2017)
Mitochondrial Cx43 hemichannels contribute to mitochondrial calcium entry and cell death in the heart
Ashish Kumar Gadicherla et al.
BASIC RESEARCH IN CARDIOLOGY (2017)
Plakophilin-2 loss promotes TGF-β1/p38 MAPK-dependent fibrotic gene expression in cardiomyocytes
Adi D. Dubash et al.
JOURNAL OF CELL BIOLOGY (2016)
Adenosine as a Multi-Signalling Guardian Angel in Human Diseases: When, Where and How Does it Exert its Protective Effects?
Pier Andrea Borea et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2016)
Central role for GSK3β in the pathogenesis of arrhythmogenic cardiomyopathy
Stephen P. Chelko et al.
JCI INSIGHT (2016)
Clinical Presentation, Long-Term Follow-Up, and Outcomes of 1001 Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Patients and Family Members
Judith A. Groeneweg et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2015)
Clinical Presentation, Long-Term Follow-Up, and Outcomes of 1001 Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Patients and Family Members
Judith A. Groeneweg et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2015)
The GSK-3 Family as Therapeutic Target for Myocardial Diseases
Hind Lal et al.
CIRCULATION RESEARCH (2015)
Missense Mutations in Plakophilin-2 Cause Sodium Current Deficit and Associate With a Brugada Syndrome Phenotype
Marina Cerrone et al.
CIRCULATION (2014)
The Hippo Pathway Is Activated and Is a Causal Mechanism for Adipogenesis in Arrhythmogenic Cardiomyopathy
Suet Nee Chen et al.
CIRCULATION RESEARCH (2014)
Arrhythmogenic cardiomyopathy and Brugada syndrome: Diseases of the connexome
Esperanza Agullo-Pascual et al.
FEBS LETTERS (2014)
Connexin defects underlie arrhythmogenic right ventricular cardiomyopathy in a novel mouse model
Robert C. Lyon et al.
HUMAN MOLECULAR GENETICS (2014)
Disease mutations in desmoplakin inhibit Cx43 membrane targeting mediated by desmoplakin-EB1 interactions
Dipal M. Patel et al.
JOURNAL OF CELL BIOLOGY (2014)
Identification of a New Modulator of the Intercalated Disc in a Zebrafish Model of Arrhythmogenic Cardiomyopathy
Angeliki Asimaki et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Remodeling of the cardiac sodium channel, connexin43, and plakoglobin at the intercalated disk in patients with arrhythmogenic cardiomyopathy
Maartje Noorman et al.
HEART RHYTHM (2013)
Genetics of Arrhythmogenic Right Ventricular Cardiomyopathy A Practical Guide for Physicians
Frank I. Marcus et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs
Changsung Kim et al.
NATURE (2013)
Intercalated disc abnormalities, reduced Na+ current density, and conduction slowing in desmoglein-2 mutant mice prior to cardiomyopathic changes
Stefania Rizzo et al.
CARDIOVASCULAR RESEARCH (2012)
Electrophysiological abnormalities precede overt structural changes in arrhythmogenic right ventricular cardiomyopathy due to mutations in desmoplakin-A combined murine and human study
John Gomes et al.
EUROPEAN HEART JOURNAL (2012)
Arrhythmogenic Cardiomyopathy: Etiology, Diagnosis, and Treatment
Srijita Sen-Chowdhry et al.
ANNUAL REVIEW OF MEDICINE (2010)
The Cardiac Desmosome and Arrhythmogenic Cardiomyopathies From Gene to Disease
Mario Delmar et al.
CIRCULATION RESEARCH (2010)
Loss of Plakophilin-2 Expression Leads to Decreased Sodium Current and Slower Conduction Velocity in Cultured Cardiac Myocytes
Priscila Y. Sato et al.
CIRCULATION RESEARCH (2009)
Myocyte necrosis underlies progressive myocardial dystrophy in mouse dsg2-related arrhythmogenic right ventricular cardiomyopathy
Kalliopi Pilichou et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Characterization of the molecular phenotype of two arrhythmogenic right ventricular cardiomyopathy (ARVC)-related plakophilin-2 (PKP2) mutations
Rosy Joshi-Mukherjee et al.
HEART RHYTHM (2008)
Left-Dominant Arrhythmogenic Cardiomyopathy
Srijita Sen-Chowdhry et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Inhibition of glycogen synthase kinase 3β during heart failure is protective
Shinichi Hirotani et al.
CIRCULATION RESEARCH (2007)
TGFβ, cardiac fibroblasts, and the fibrotic response
Andrew Leask
CARDIOVASCULAR RESEARCH (2007)
Suppression of canonical Wnt/β-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy
Eduardo Garcia-Gras et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Plakophilin-2 mutations are the major determinant of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy
JP van Tintelen et al.
CIRCULATION (2006)
Remodeling of myocyte gap junctions in arrhythmogenic right ventricular cardiomyopathy due to a deletion in plakoglobin (Naxos disease)
SR Kaplan et al.
HEART RHYTHM (2004)
Genetic deletion of glycogen synthase kinase-3β abrogates activation of IκBα kinase, JNK, Akt, and p44/p42 MAPK but potentiates apoptosis induced by tumor necrosis factor
Y Takada et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
分享论文
